Schrödinger, Inc. (SDGR)

NASDAQ: SDGR · Real-Time Price · USD
23.88
+0.16 (0.67%)
May 8, 2025, 4:00 PM EDT - Market closed
0.67%
Market Cap 1.75B
Revenue (ttm) 230.49M
Net Income (ttm) -192.21M
Shares Out 73.38M
EPS (ttm) -2.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,363,949
Open 24.47
Previous Close 23.72
Day's Range 22.69 - 24.88
52-Week Range 16.60 - 28.47
Beta 1.84
Analysts Buy
Price Target 32.80 (+37.35%)
Earnings Date May 7, 2025

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration an... [Read more]

Sector Healthcare
IPO Date Feb 6, 2020
Employees 891
Stock Exchange NASDAQ
Ticker Symbol SDGR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $32.8, which is an increase of 37.35% from the latest price.

Price Target
$32.8
(37.35% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Schrödinger, Inc. (SDGR) Q1 2025 Earnings Call Transcript

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Affairs Ramy Farid - ...

1 day ago - Seeking Alpha

Schrödinger Reports Strong First Quarter 2025 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced financial results for the quarter ended March 31, 2025.

1 day ago - Business Wire

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference. The live presentation...

3 days ago - Business Wire

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

CHICAGO--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) presented preclinical data on SGR-3515, its investigational Wee1/Myt1 co-inhibitor today at the American Association for Cancer Research (AAC...

10 days ago - Business Wire

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the financial markets close.

15 days ago - Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2025, the company granted (i) a non-statutory stock option to purchase 3,300 shares of the company's common...

20 days ago - Business Wire

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration's (FDA) plan to reduce, refine or potentially replace current animal testing require...

24 days ago - Business Wire

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade)

Schrödinger's stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug discovery platform. The company has strong collaborations with big pharma and a pro...

26 days ago - Seeking Alpha

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025.

2 months ago - Business Wire

Schrödinger: Still Waiting On A Catalyst

Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the compan...

2 months ago - Seeking Alpha

Schrödinger, Inc. (SDGR) Q4 2024 Earnings Call Transcript

Schrödinger, Inc. (NASDAQ:SDGR) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Affairs Ramy Fa...

2 months ago - Seeking Alpha

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results.

2 months ago - Business Wire

Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside chat...

2 months ago - Business Wire

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close.

3 months ago - Business Wire

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025. “We are very proud of ...

4 months ago - Business Wire

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

NEW YORK--(BUSINESS WIRE)--Schrödinger broadens and accelerates predictive toxicology initiative.

6 months ago - Business Wire

Schrödinger (SDGR) Q3 2024 Earnings Call Transcript

Schrödinger Inc. (NASDAQ:SDGR) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Ramy Farid - President, Chief Executive Officer Karen Akinsanya - President, R&D and ...

6 months ago - Seeking Alpha

Schrödinger Reports Third Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced financial results for the third quarter of 2024 and provided a business update.

6 months ago - Business Wire

Schrödinger to Present at Jefferies London Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference.

6 months ago - Business Wire

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its third quarter 2024 financial results on Tuesday, November 12, 2024, before the financial markets open.

6 months ago - Business Wire

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR Symp...

7 months ago - Business Wire

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and the company's PRMT5-MTA inhibitor program, wil...

7 months ago - Business Wire

Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm

NEW YORK , Sept. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their...

8 months ago - PRNewsWire

Schrödinger, Inc. (SDGR) Q2 2024 Earnings Call Transcript

Schrödinger, Inc. (NASDAQ:SDGR) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Communications Ramy...

10 months ago - Seeking Alpha

Schrödinger Reports Strong Second Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced financial results for the second quarter of 2024.

10 months ago - Business Wire